OTC Markets OTCPK - Delayed Quote USD

Entourage Health Corp. (ETRGF)

Compare
0.0081 -0.0004 (-4.71%)
As of October 8 at 4:00 PM EDT. Market Open.
Loading Chart for ETRGF
DELL
  • Previous Close 0.0085
  • Open 0.0085
  • Bid 0.0075 x --
  • Ask 0.0087 x --
  • Day's Range 0.0085 - 0.0085
  • 52 Week Range 0.0021 - 0.0180
  • Volume 49,825
  • Avg. Volume 23,020
  • Market Cap (intraday) 2.498M
  • Beta (5Y Monthly) 1.08
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1000
  • Earnings Date Nov 25, 2024 - Nov 29, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary's Medicinals, and Royal City Cannabis brand names. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health Corp. is headquartered in Aylmer, Canada.

entouragehealthcorp.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ETRGF

View More

Performance Overview: ETRGF

Trailing total returns as of 10/9/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ETRGF
14.74%
S&P/TSX Composite index
15.44%

1-Year Return

ETRGF
38.64%
S&P/TSX Composite index
25.71%

3-Year Return

ETRGF
94.00%
S&P/TSX Composite index
18.51%

5-Year Return

ETRGF
99.19%
S&P/TSX Composite index
48.49%

Compare To: ETRGF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ETRGF

View More

Valuation Measures

Annual
As of 10/8/2024
  • Market Cap

    2.27M

  • Enterprise Value

    129.02M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.08

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    4.31

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -107.45%

  • Return on Assets (ttm)

    -36.79%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    40.67M

  • Net Income Avi to Common (ttm)

    -43.7M

  • Diluted EPS (ttm)

    -0.1000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.59M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -17.58M

Company Insights: ETRGF

People Also Watch